NCT00269750View on ClinicalTrials.gov

A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence.

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 1996

Study Completion Date

February 28, 1997

Conditions
Urge Incontinence
Interventions
DRUG

OROS® oxybutynin or Ditropan®

All Listed Sponsors
lead

Alza Corporation, DE, USA

INDUSTRY

NCT00269750 - A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence. | Biotech Hunter | Biotech Hunter